1. Which of the following components of a pharmacist-led AF screening model is essential to its success?

2. Which of the following individuals is at high risk for undiagnosed AF?

3. You have set up an AF screening booth at a health fair sponsored by a community organization in a rural area of your state. Consistent with AF screening models used successfully at some colleges of pharmacy, which of the following healthcare professionals would confirm the results among individuals who fail screening?

4. Patricia, a 57-year-old woman, failed a single-lead ECG screening for AF at a health fair. She is surprised by the recommendation to follow up with her primary care physician and wonders if it's really necessary, since she feels “perfectly fine.” What individualized recommendation about following up with her physician would you give her?

5. Patricia's primary care physician confirms the AF diagnosis and prescribes warfarin based on her risk of stroke. About 2 months after initiating warfarin, Patricia is refilling her prescription and complains that the INR monitoring and dietary restrictions are inconvenient. She asks about switching to a NOAC, but would first like to know how a NOAC compares with warfarin in terms of bleeding risks and stroke prevention. What advice will you give her?

6. Terrence is 66-year-old man with a 4-year history of type 2 diabetes who presents to your primary care clinic for a routine annual physical. What form of AF screening, if any, would you perform during this visit?

7. Deidre is a 72-year-old woman with long-standing hypertension that is managed with amlodipine and hydrochlorothiazide. She has no other comorbidities or medications. Deidre scheduled an appointment with you, her primary care physician, after failing a pharmacist-led AF screening test. You confirm the diagnosis of AF. What changes, if any, will you make to her medications?

« Return to Activity